NCT04021394View on ClinicalTrials.gov

Influence of EMT on CTCs and Disease Progression in Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

June 5, 2019

Primary Completion Date

April 27, 2021

Study Completion Date

December 1, 2022

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

CellSearch CTC platform

epithelial-based marker approach for immunomagnetic enrichment, isolation, and quantitative immunofluorescence of CTCs

DIAGNOSTIC_TEST

Parsortix CTC platform

EMT-independent platform

Trial Locations (1)

N6A 5W9

London Regional Cancer Program, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT04021394 - Influence of EMT on CTCs and Disease Progression in Prostate Cancer | Biotech Hunter | Biotech Hunter